Clinical trials and surrogate end points: lessons from the ENHANCE trial

ISSN： 1746-0875

Source： Future Lipidology, Vol.3, Iss.4, 2008-08, pp. : 353-357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A unified procedure for meta-analytic evaluation of surrogate end points in randomized clinical trials

By Dai James Y. Hughes James P.

Biostatistics, Vol. 13, Iss. 4, 2012-09 ,pp. : 609-624

Oxford University Press

Access to resources Recommend Favorite

Surrogate end points: when should they be used?

By Molenberghs Geert Abad Ariel Alonso van der Elst Wim Burzykowski Tomasz Buyse Marc

Clinical Investigation, Vol. 3, Iss. 12, 2013-12 ,pp. : 1147-1155

Future Science

Access to resources Recommend Favorite

TGN-1412 and BIA-2474 Trials with Tragic End: Lessons Learnt To Make Clinical Trials Safer

Reviews on Recent Clinical Trials, Vol. 13, Iss. 4, 2018-12 ,pp. : 252-256

Bentham Science Publishers

Access to resources Recommend Favorite

Shift From Surrogate End Point to Outcome Trials: Implications for Cardiovascular Safety Assessment in Development Programs for Antidiabetic Drugs

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 3, 2012-03 ,pp. : 514-520

John Wiley & Sons Inc

Access to resources Recommend Favorite

Methodological aspects and the interpretation of clinical trial data: lessons from the TEAR trial

By Fleischmann Roy

British Journal of Rheumatology , Vol. 52, Iss. 3, 2013-03 ,pp. : 409-410

Oxford University Press

Access to resources Recommend Favorite